Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 3
1996 1
1998 2
1999 3
2002 2
2004 2
2005 4
2006 5
2007 7
2008 8
2009 14
2010 12
2011 11
2012 8
2013 12
2014 10
2015 5
2016 11
2017 10
2018 7
2019 9
2020 167
2021 144
2022 56
2023 27
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

486 results

Results by year

Filters applied: . Clear all
Page 1
Arbidol as a broad-spectrum antiviral: an update.
Blaising J, Polyak SJ, Pécheur EI. Blaising J, et al. Antiviral Res. 2014 Jul;107:84-94. doi: 10.1016/j.antiviral.2014.04.006. Epub 2014 Apr 24. Antiviral Res. 2014. PMID: 24769245 Free PMC article. Review.
Arbidol (ARB) is a Russian-made small indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and other respiratory viral infections. ...
Arbidol (ARB) is a Russian-made small indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influ …
Arbidol.
[No authors listed] [No authors listed] Drugs R D. 1999 Sep;2(3):171-2. doi: 10.2165/00126839-199902030-00003. Drugs R D. 1999. PMID: 10641219 No abstract available.
Antivirals for COVID-19.
Srinivas P, Sacha GL, Koval C. Srinivas P, et al. Cleve Clin J Med. 2020 Oct 7. doi: 10.3949/ccjm.87a.ccc030. Online ahead of print. Cleve Clin J Med. 2020. PMID: 32409433 Free article.
Antivirals to treat influenza (oseltamivir) have limited activity against SARS-CoV-2, but favipiravir and umifenovir, two influenza antivirals available internationally, may have distinct viral targets and require further investigation. ...
Antivirals to treat influenza (oseltamivir) have limited activity against SARS-CoV-2, but favipiravir and umifenovir, two influenza a …
A trial of arbidol hydrochloride in adults with COVID-19.
Zhao J, Zhang J, Jin Y, Tang Z, Hu K, Sun H, Shi M, Yang Q, Gu P, Guo H, Li Q, Zhang H, Li C, Yang M, Xiong N, Dong X, Xu J, Lin F, Wang T, Yang C, Huang B, Zhang J, Chen S, He Q, Zhou M, Qu J. Zhao J, et al. Chin Med J (Engl). 2022 Jul 14;135(13):1531-8. doi: 10.1097/CM9.0000000000002104. Online ahead of print. Chin Med J (Engl). 2022. PMID: 35830201 Free PMC article.
Patients were stratified 1:2 to either standard-of-care (SOC) or SOC plus arbidol tablets (oral administration of 200 mg per time, three times a day for 14 days). ...Moreover, the addition of arbidol tablets to SOC led to more rapid normalization of declined blood l …
Patients were stratified 1:2 to either standard-of-care (SOC) or SOC plus arbidol tablets (oral administration of 200 mg per time, th …
Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis.
Amani B, Amani B, Zareei S, Zareei M. Amani B, et al. Immun Inflamm Dis. 2021 Dec;9(4):1197-1208. doi: 10.1002/iid3.502. Epub 2021 Aug 4. Immun Inflamm Dis. 2021. PMID: 34347937 Free PMC article. Review.
OBJECTIVE: To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID-19 treatment. METHODS: A literature systematic search was carried out in PubMed, Cochrane Library, Embase, and medRxiv up to May 2021. ...There was no significant …
OBJECTIVE: To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID-19 treatment. METHODS: …
Potential strategies for combating COVID-19.
Shamim S, Khan M, Kharaba ZJ, Ijaz M, Murtaza G. Shamim S, et al. Arch Virol. 2020 Nov;165(11):2419-2438. doi: 10.1007/s00705-020-04768-3. Epub 2020 Aug 10. Arch Virol. 2020. PMID: 32778950 Free PMC article. Review.
Arbidol: The current demand, strategies, and antiviral mechanisms.
Kang Y, Shi Y, Xu S. Kang Y, et al. Immun Inflamm Dis. 2023 Aug;11(8):e984. doi: 10.1002/iid3.984. Immun Inflamm Dis. 2023. PMID: 37647451 Free PMC article. Review.
However, highly viral gene mutation has underscored the necessity of novel antiviral drug development. Arbidol (ARB) is a Russian-made indole-derivative small molecule licensed in Russia and China for the prevention and treatment of influenza and other respiratory viral in …
However, highly viral gene mutation has underscored the necessity of novel antiviral drug development. Arbidol (ARB) is a Russian-mad …
Interferon-α2b Treatment for COVID-19.
Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Zhou Q, et al. Front Immunol. 2020 May 15;11:1061. doi: 10.3389/fimmu.2020.01061. eCollection 2020. Front Immunol. 2020. PMID: 32574262 Free PMC article. Clinical Trial.
In this uncontrolled, exploratory study, 77 adults hospitalized with confirmed COVID-19 were treated with either nebulized IFN-alpha2b (5 mU b.i.d.), arbidol (200 mg t.i.d.) or a combination of IFN-alpha2b plus arbidol. Serial SARS-CoV-2 testing along with hematolog …
In this uncontrolled, exploratory study, 77 adults hospitalized with confirmed COVID-19 were treated with either nebulized IFN-alpha2b (5 mU …
Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials.
Siordia JA Jr, Bernaba M, Yoshino K, Ulhaque A, Kumar S, Bernaba M, Bergin E. Siordia JA Jr, et al. SN Compr Clin Med. 2020;2(8):1120-1131. doi: 10.1007/s42399-020-00399-6. Epub 2020 Jul 15. SN Compr Clin Med. 2020. PMID: 32838169 Free PMC article. Review.
Review of literature showed no significant clinical improvement with lopinavir/ritonavir, arbidol, hydroxychloroquine, or remdesivir. Tocilizumab showed mixed results regarding survival. Favipiravir showed quicker symptom improvement compared to lopinavir/ritonavir and …
Review of literature showed no significant clinical improvement with lopinavir/ritonavir, arbidol, hydroxychloroquine, or remdesivir. …
An update of anti-viral treatment of COVID-19.
Şimşek-Yavuz S, Komsuoğlu Çelikyurt FI. Şimşek-Yavuz S, et al. Turk J Med Sci. 2021 Dec 17;51(SI-1):3372-3390. doi: 10.3906/sag-2106-250. Turk J Med Sci. 2021. PMID: 34391321 Free PMC article. Review.
The main drug groups include inhibitors of viral entry into the human cell (convalescent plasma, monoclonal antibodies, nanobodies, mini proteins, human soluble ACE-2, camostat, dutasteride, proxalutamide, bromhexin, hydroxychloroquine, umifenovir nitazoxanid, niclosamide, …
The main drug groups include inhibitors of viral entry into the human cell (convalescent plasma, monoclonal antibodies, nanobodies, mini pro …
486 results